Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DX26FL476
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a specific purchase order under DMS Pharmaceutical Group's broader prime vendor contract. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, which was awarded on November 13, 2025, as part of the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. This contract positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors within the broader $30.3 billion PPV-G GEN V acquisition strategy, enabling the DLA to issue firm fixed-price delivery orders for diverse pharmaceutical requirements across military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DX26FL476?
SPE2DX26FL476 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on November 7, 2025.
How much is contract SPE2DX26FL476 worth?
The government has obligated $4,170 on SPE2DX26FL476.
Is contract SPE2DX26FL476 an order under another contract?
Yes. SPE2DX26FL476 is a delivery order under SPE2DX16D9414, an indefinite delivery contract.
Was contract SPE2DX26FL476 competed?
The extent of competition for SPE2DX26FL476 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award